Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of RGT-274-CR capsules in adults with type 2 diabetes mellitus
CTR20262793Phase 2Active
- Sponsor
- Regor Therapeutics
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RGT-274 in type 2 diabetes mellitus (T2DM), sponsored by Regor Therapeutics. Started Jul 2026; status: active.
02
Drugs
RGT-274
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20262793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262793.